It is known that increased prolactin levels in cases with prolactinoma cause obesity, insulin resistance, an increase in homocysteine levels and low-grade inflammation and subsequently a tendency to cardiovascular diseases [46, 47]. The gene discussed is PRL; the disease is Insulin resistance.